Dossier assessment
Vildagliptin - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Report documents
-
Extract of dossier assessment
Vildagliptin - Benefit assessment according to §35a Social Code Book V (dossier assessment)
-
Dossier assessment
Vildagliptin - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Press releases
Vildagliptin for type 2 diabetes: no suitable data for combination with sulfonylurea
New study not only compared drugs / effects might have been caused by different therapeutic strategies alone
Project details
- Project no.
- A14-46
- Commission
- Commission awarded on 03.12.2014 by the Federal Joint Committee (GBA).
- Report type
- Dossier assessment
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Digestion, metabolism and hormones
- Note
-
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
Connected Projects
-
Dossier assessment
Vildagliptin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Status: Commission completed